Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

AI-Guided Bronchoscopy Using the Broncho AI Navigator

12. november 2026 oppdatert av: Ambu A/S

Real-Time AI-Guided Bronchoscopy: A Two-Phase Clinical Study Evaluating Usability and Impact on Procedural Performance Metrics of the Broncho AI Navigator

This clinical investigation evaluates the Ambu Broncho AI Navigator, an investigational software system designed to provide real-time navigational support during bronchoscopy. The system uses artificial intelligence to identify and display airway anatomy during procedures and to help bronchoscopists track which airway segments have been examined.

The study is conducted at Odense University Hospital and consists of two phases. In Phase 2a, experienced bronchoscopists use the system during routine bronchoscopies to evaluate and optimize technical settings and usability. For this phase 45 patients will be enrolled. In Phase 2b, bronchoscopies are randomized (1:1) to be performed with or without the Broncho AI Navigator to evaluate the impact of AI guidance on procedural performance. For this phase 108 patients will be enrolled.

Adult patients undergoing elective bronchoscopy are enrolled, while the primary study subjects are the bronchoscopists performing the procedures. The study evaluates whether use of the Broncho AI Navigator improves bronchoscopy performance by increasing diagnostic completeness, improving structured progression through the bronchial tree, and reducing procedure time. The findings will support further development and future validation of the Broncho AI Navigator in clinical practice.

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

153

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Region Syddanmark
      • Odense, Region Syddanmark, Danmark, 5000
        • Rekruttering
        • Odense University Hospital
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Phase 2a (System calibration):

Inclusion Criteria:

  • Patients indicated for bronchoscopy of central airways as per standard of care.
  • Patients with an age of 18 years or above.

Exclusion Criteria:

  • Patients who are unable to cooperate for bronchoscopy (e.g., patients with mental disorders, cognitive impairment, psychological disorder).
  • Patients who are unable or unwilling to give informed consent.
  • Patients with highly abnormal lung anatomy.
  • Patients with conditions which significantly impact the visual appearance of the airway tissue, such as heavy bleeding, secretions, or inflammation.
  • Patients who are pregnant or breastfeeding
  • Patients previously enrolled in either phase 2a

Phase 2b (Randomized study):

Inclusion Criteria:

  • Patients indicated for bronchoscopy of central airways as per standard of care.
  • Patients with an age of 18 years or above.

Exclusion Criteria:

  • Patients who are unable to cooperate for bronchoscopy (e.g., patients with mental disorders, cognitive impairment, psychological disorder).
  • Patients who are unable or unwilling to give informed consent.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Broncho AI Navigator

The Broncho AI Navigator is an investigational software device designed to provide real-time navigational support during bronchoscopy. The system analyzes live bronchoscopy video using artificial intelligence to identify anatomical landmarks and bronchial segments and displays this information on a monitor to assist navigation through the tracheobronchial tree. The software is evaluated as an adjunct to standard bronchoscopy procedures.

Ingen inngripen: Standard Bronchoscopy

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Diagnostic completeness
Tidsramme: At the time of the procedure

Diagnostic completeness is defined as the bronchoscopist's ability to visualize all available tertiary bronchial segments (RB1, RB2, RB3, RB4, RB5, RB6, RB7, RB8, RB9, RB10, LB1+2, LB3, LB4, LB5, LB6, LB8, LB9, and LB10) using the bronchoscope. For the purpose of this investigation, a procedure is considered fully diagnostically complete (score of 1) if all tertiary segments are visualized. If any segments are not visualized, the procedure is deemed diagnostically incomplete (score of 0).

At the time of the procedure
Structured progression
Tidsramme: At the time of the procedure

The structured progression outcome is scored between 0 and 18, with 18 indicating 18 correct progressions. A point is awarded when the bronchoscopist visualizes one segment and then immediately proceeds to the succeeding segment (e.g., visualizing RB1 followed by RB2 results in a point, whereas RB2 followed by RB1 does not).

At the time of the procedure
Procedure time
Tidsramme: At the time of the procedure

Procedure time is defined as the duration required for the bronchoscopist to visualize all 18 segments, starting from the visualization of the first segment to the last.

At the time of the procedure

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Samarbeidspartnere

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

14. september 2026

Primær fullføring (Antatt)

30. mai 2027

Studiet fullført (Antatt)

30. mai 2028

Datoer for studieregistrering

Først innsendt

12. november 2026

Først innsendt som oppfylte QC-kriteriene

12. november 2026

Først lagt ut (Faktiske)

18. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

12. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • CIS-030
  • 16-0300-55 (Annen identifikator: Medical Research Ethics Committees (MREC), Denmark)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data (IPD) will not be made publicly available. The study includes clinical procedure data and video recordings collected for medical device development and evaluation. Data contain information that could increase the risk of re-identification, and sharing is restricted to protect participant privacy and confidentiality in accordance with applicable data protection requirements.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere